Last reviewed · How we verify
albendazole plus praziquantel regime
At a glance
| Generic name | albendazole plus praziquantel regime |
|---|---|
| Also known as | Comparison regimen |
| Sponsor | Universidad Peruana Cayetano Heredia |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Oxfendazole in Mild Parenchymal Brain Cysticercosis (PHASE2, PHASE3)
- Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: